McAfee SECURE sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
Call Us Toll Free
Doctor Endorsements
Our practice has been recommending VisiVite Dry Eye Relief TG-1000 to every dry eye patient we see. The patients love it. They feel a great relief from not having to constantly feel a burning or itching sensation and being free of hourly tear drops. Our practice recommends these products to everyone!
Monique M. Barbour, M.D.
We see approximately 120 patients per week with about 15% having or being at risk for macular degeneration. Using the AREDS as our reference we became aware of the importance of nutritional supplements in the prevention of the progression of macular degeneration. This along with various other studies on the importance of vitamins for general eye health and AREDS2 prompted us to look for a supplement that fit the needs of our patients. Visivite showed itself to be the only company who took pains to offer the ratio of different vitamins supported by this research.
Dr. Kendal Piatt, O.D.
We have been recommending VisiVite for several years. AREDS2 formulation vitamins are the mainstay in the treatment of dry AMD which affects about 1.7 million Americans. We find that the VisiVite vitamins fit the needs of our patients. We can recommend different formulations based on the patients' history. The quality is unsurpassed, they are well tolerated which increases patient compliance. At "Island Retina" our mission statement is to provide outstanding retinal care in a warm and supportive environment. I have been practicing for more than 20 years. We love taking care of patients with retinal disease including diabetes, macular degeneration and retinal detachments. Our practice is unique in that we have a surgery center,we are involved in several national research projects as well as our own research, and we have a satelite office in Commack, NY. I do a great deal of lecturing throughout the country as part of my committment to education.
Pamela Weber, M.D.
Retinal Surgeon
East Florida Eye Institute specializes in the treatment of Macular Degeneration, Glaucoma, Diabetic Eye Disease, and Dry Eye Disease. We recommend the use of VisiVite for all of our Macular Degeneration patients.
Ronald E. P. Frenkel, M.D.
We recommend that all of our patients take VisiVite AREDS2-based vitamins, due to the evidence based nature of the formula.
Marc Lay, OD
I've been in practice for 36 years. We see many patients with Macular Degeneration and dry eyes. As a general Ophthalmologist, I see patients with varying Eye problems including cataracts and glaucoma. Based on the AREDS2 study, a vitamin like Visivite is the only treatment for Macular Degeneration available today.
Martin L Weinhoff, MD
This combination of nutrients, found in supplements like Ocuvite and VisiVite, is now widely recommended for people with moderate or severe macular degeneration. Current or former smokers may be better off with VisiVite's Smoker's Formula, which leaves out the beta-carotene (beta-carotene supplements my increase the risk of lung cancer in smokers).
Marvin Moe Bell, M.D., M.P.H.
Physician and Author
I recommend VisiVite to all my macular degeneration patients. Based on the latest AREDS2 study, lutein and zeaxanthin absorption was increased when beta-carotene was eliminated. Therefore, I advise all my AMD patients to take VisiVite AREDS2 Plus+ Gold Formula for maximal protection, as it contains all the necessary ingredients as recommended by this latest research.

Dr. Cohen is a distinguished Fellow of The American Academy of Optometry.
Dr. Madeline Cohen, O.D.
Optometrist, F.A.A.O.
Since 2000, the methods of diagnosis and treatment of macular degeneration have exploded. No longer is the disease guaranteed to progress and cause blindness.

What is Macular Degeneration?

anatomy of maculaMacular degeneration is a disease of the part of the retina that provides central or "detail" vision. This central part of the retina, known as the macula, allows the eye to read numbers and letters and recognize faces.

The majority of cases of macular degeneration are due to aging, and are thus called Age-Related Macular Degeneration. However, there are other forms of macular degeneration, including congenital macular degeneration conditions such as Stargardt's Disease, and a form related to severe near-sightedness, called Myopic Macular Degeneration.

The findings of macular degeneration differ depending on the type:

  • Dry Macular Degeneration (Atrophic Macular Degeneration): Notable for atrophy or thinning of the macula as well as the formation of collections of lipofuscin in the macula, which are known as drusen.
  • Wet Macular Degeneration (Exudative Macular Degeneration): Characterized by the formation of abnormal blood vessels (neovascularization) beneath the retina, which results in bleeding, leakage of protein, and rapid damage to the retina if left untreated.

The diagnosis and treatment of macular degeneration have improved since 2000 due to three major factors:

1. Diagnosis:

Previously, doctors would assess using a direct ophthalmoscope or sometimes indirect ophthalmoscopy. If there were suspicions of the macular degeneration progressing, for example dry macular degeneration becoming wet macular degeneration, doctors would perform fundus photography or sometimes fluorescein angiography. However, the advent of OCT (ocular coherence tomography) [see image below] has made the process of evaluating the degree of macular degeneration rapid, easy and painless.
OCT of wet macular degeneration

2. Prevention:

The National Eye Institute published the first AREDS (Age Related Eye Disease Study) in 2001 and other studies have been published since that document the benefit to high dose nutritional supplements in slowing the progression of disease. Additionally, research now proves that there may be a genetic component to many cases of macular degeneration. Rather than be a negative, this has encouraged family members of patients who have macular degeneration to seek more frequent and early care.

3. Treatment:

The recent development of medications that cause the neovascular blood vessels of wet macular degeneration to recede (Lucentis, Avastin, Eyelea) mean that the devastating effects of wet macular degeneration may be halted. The downsides to these medications thus far is that they need to be repeatedly injected into the eyeball, and they have added a huge new medical cost that previously did not exist. However, the fact that they have the ability to stop blindness has created a hopeful quality of life for those affected.

Charities We Support
VisiviteVisiviteVisiviteAREDSFloraGLOONSCRNMSSMRPBColumbioa University